Eli Lilly Expands Zepbound Vial Choices, Lowers Costs For two.5 mg, 5 Mg Doses – Eli Lilly (NYSE:LLY)

On Tuesday, Eli Lilly And Co LLY launched 7.5 mg and 10 mg Zepbound (tirzepatide) single-dose vials, accessible for $499 with the brand new Zepbound Self Pay Journey Program. Eli Lilly additionally diminished the worth of the two.5 mg and 5 mg vials.

These new choices can be found solely by way of LillyDirect Self-Pay Pharmacy Options, which permits a clear value by eradicating third-party provide chain entities and permitting sufferers to entry financial savings straight exterior of insurance coverage.

Additionally Learn: Eli Lilly Seeks To Develop Into Most cancers Radiopharma And Fatty Liver, With Two World Offers

Self-pay sufferers with weight problems now have extra Zepbound vial choices, together with 2.5 mg, 5 mg, 7.5 mg, and 10 mg doses. Along with increasing the doses accessible, Lilly is taking steps to make Zepbound vials extra reasonably priced, together with:

• Decreasing the worth of the two.5 mg dose to $349 monthly.
• Decreasing the worth of the 5 mg dose to $499 monthly.
• Launching the Zepbound Self Pay Journey Program, which reduces the worth of the 7.5 mg ($599) and 10 mg ($699) doses to $499 monthly at first fill and refills that happen inside 45 days of prior supply.

Zepbound can be accessible in 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, or 15 mg per 0.5 mL doses in a single-dose pen (autoinjector).

The really helpful upkeep dosages are 5 mg, 10 mg or 15 mg injected subcutaneously as soon as weekly.

These beginning on Zepbound will take Zepbound 2.5 mg for 4 weeks earlier than growing their dosage to five mg. 

Zepbound gross sales within the fourth quarter reached $1.91 billion, up from $175.8 million a yr in the past. Annual gross sales reached $4.93 billion.

In August 2024, Eli Lilly launched vials containing low doses of its weight-loss drug Zepbound (tirzepatide). Zepbound 2.5 mg and 5 mg single-dose vials are accessible for self-pay for sufferers with an on-label prescription, considerably increasing the availability of Zepbound in response to excessive demand.

Worth Motion: LLY inventory is up 1.6% at $896 in the course of the premarket session eventually examine Tuesday.

Learn Subsequent:

Photograph: Shutterstock